| Year |
Citation |
Score |
| 2020 |
Fishman M, Wenzel K, Scodes J, Pavlicova M, Lee JD, Rotrosen J, Nunes E. Young Adults Have Worse Outcomes Than Older Adults: Secondary Analysis of a Medication Trial for Opioid Use Disorder. Journal of Adolescent Health. PMID 32873500 DOI: 10.1016/J.Jadohealth.2020.07.038 |
0.33 |
|
| 2020 |
Randesi M, Rotrosen J, Nunes EV, Lee JD, Novo P, Levran O, Ott J, Pavlicova M, Scodes J, Kreek MJ. Variants of opioid genes and response to treatment of opioid use disorder with buprenorphine-naloxone versus extended-release naltrexone in Caucasians. The American Journal of Drug and Alcohol Abuse. 1-8. PMID 32851876 DOI: 10.1080/00952990.2020.1797064 |
0.337 |
|
| 2020 |
Haeny AM, Montgomery L, Burlew AK, Campbell ANC, Scodes J, Pavlicova M, Rotrosen J, Nunes E. Extended-release naltrexone versus buprenorphine-naloxone to treat opioid use disorder among black adults. Addictive Behaviors. 110: 106514. PMID 32619868 DOI: 10.1016/J.Addbeh.2020.106514 |
0.392 |
|
| 2020 |
Blevins D, Choi CJ, Pavlicova M, Martinez D, Mariani JJ, Grabowski J, Levin FR. Impulsiveness as a moderator of amphetamine treatment response for cocaine use disorder among ADHD patients. Drug and Alcohol Dependence. 213: 108082. PMID 32485656 DOI: 10.1016/J.Drugalcdep.2020.108082 |
0.331 |
|
| 2020 |
Barbosa-Leiker C, Campbell ANC, Pavlicova M, Scodes J, Burlew AK, Hatch-Maillette M, Mennenga SE, Mitchell SG, Novo P, Nunes EV, Rotrosen J, Greenfield SF. Substance Use and Mental Health in Emerging Adult Vs Older Adult Men and Women With Opioid Use Disorder. The American Journal On Addictions. PMID 32438502 DOI: 10.1111/Ajad.13059 |
0.312 |
|
| 2020 |
Saraiya TC, Pavlicova M, Hu MC, Nunes EV, Hien DA, Campbell ANC. Exploring gender differences among treatment-seekers who use opioids versus alcohol and other drugs. Women & Health. 1-18. PMID 32233747 DOI: 10.1080/03630242.2020.1746952 |
0.382 |
|
| 2020 |
Shulman M, Luo S, Campbell ANC, Scodes J, Pavlicova M, Broffman A, Saxon AJ, Nunes EV. Secondary Analysis of Pain Outcomes in a Large Pragmatic Randomized Trial of Buprenorphine/Naloxone Versus Methadone for Opioid Use Disorder. Journal of Addiction Medicine. PMID 32039934 DOI: 10.1097/Adm.0000000000000630 |
0.345 |
|
| 2020 |
Spector AY, Pavlicova M, Hu MC, Nunes EV, Campbell ANC, Tross S. Predictors of HIV sex risk behavior among women in US drug treatment programs: NIDA CTN trial results Journal of Hiv/Aids & Social Services. 19: 90-106. DOI: 10.1080/15381501.2020.1712290 |
0.35 |
|
| 2019 |
Dakwar E, Levin F, Hart CL, Basaraba C, Choi J, Pavlicova M, Nunes EV. A Single Ketamine Infusion Combined With Motivational Enhancement Therapy for Alcohol Use Disorder: A Randomized Midazolam-Controlled Pilot Trial. The American Journal of Psychiatry. appiajp201919070684. PMID 31786934 DOI: 10.1176/Appi.Ajp.2019.19070684 |
0.345 |
|
| 2019 |
Levin FR, Mariani JJ, Pavlicova M, Choi CJ, Mahony AL, Brooks DJ, Bisaga A, Dakwar E, Carpenter KM, Naqvi N, Nunes EV, Kampman K. Extended release mixed amphetamine salts and topiramate for cocaine dependence: A randomized clinical replication trial with frequent users. Drug and Alcohol Dependence. 107700. PMID 31753736 DOI: 10.1016/J.Drugalcdep.2019.107700 |
0.344 |
|
| 2019 |
Ruglass LM, Scodes J, Pavlicova M, Campbell ANC, Fitzpatrick S, Barbosa-Leiker C, Burlew K, Greenfield SF, Rotrosen J, Nunes EV. Trajectory classes of opioid use among individuals in a randomized controlled trial comparing extended-release naltrexone and buprenorphine-naloxone. Drug and Alcohol Dependence. 205: 107649. PMID 31704382 DOI: 10.1016/J.Drugalcdep.2019.107649 |
0.369 |
|
| 2019 |
Paschen-Wolff MM, Campbell ANC, Tross S, Choo TH, Pavlicova M, Jarlais DD. DSM-5 substance use disorder symptom clusters and HIV antiretroviral therapy (ART) adherence. Aids Care. 1-6. PMID 31682153 DOI: 10.1080/09540121.2019.1686600 |
0.345 |
|
| 2019 |
Vaezazizi LM, Campbell ANC, Pavlicova M, Hu MC, Nunes EV. Understanding site variability in a multisite clinical trial of a technology-delivered psychosocial intervention for substance use disorders. Journal of Substance Abuse Treatment. 105: 64-70. PMID 31443894 DOI: 10.1016/J.Jsat.2019.03.003 |
0.329 |
|
| 2019 |
Dakwar E, Mahony A, Choi CJ, Pavlicova M, Brooks D, Mariani JP, Levin FR. Guanfacine extended-release for cannabis use disorder: a pilot feasibility trial. The American Journal of Drug and Alcohol Abuse. 1-5. PMID 31339797 DOI: 10.1080/00952990.2019.1620259 |
0.355 |
|
| 2019 |
Dakwar E, Nunes EV, Hart CL, Foltin RW, Mathew SJ, Carpenter KM, Choi CJJ, Basaraba CN, Pavlicova M, Levin FR. A Single Ketamine Infusion Combined With Mindfulness-Based Behavioral Modification to Treat Cocaine Dependence: A Randomized Clinical Trial. The American Journal of Psychiatry. appiajp201918101123. PMID 31230464 DOI: 10.1176/Appi.Ajp.2019.18101123 |
0.334 |
|
| 2019 |
Marino LA, Campbell ANC, Pavlicova M, Hu M, Nunes EV. Social functioning outcomes among individuals with substance use disorders receiving internet-delivered community reinforcement approach. Substance Use & Misuse. 1-8. PMID 30849925 DOI: 10.1080/10826084.2018.1528458 |
0.309 |
|
| 2019 |
Brewster KK, Stein A, Pavlicova M, Chen C, Brown P, Kim A, Golub J, Galatioto J, Olson E, Kuhlmey M, Roose S, Brickman A, Rutherford B. Hearing Aids And Late-Life Depression: A Methods Study American Journal of Geriatric Psychiatry. 27. DOI: 10.1016/J.Jagp.2019.01.019 |
0.307 |
|
| 2018 |
McIntyre KM, Mogle JA, Scodes JM, Pavlicova M, Shapiro PA, Gorenstein EE, Tager FA, Monk C, Almeida DM, Sloan RP. Anger-reduction treatment reduces negative affect reactivity to daily stressors. Journal of Consulting and Clinical Psychology. PMID 30507214 DOI: 10.1037/Ccp0000359 |
0.341 |
|
| 2018 |
Sullivan MA, Bisaga A, Pavlicova M, Carpenter KM, Choi CJ, Mishlen K, Levin FR, Mariani JJ, Nunes EV. A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use Disorder. The American Journal of Psychiatry. appiajp201817070732. PMID 30336703 DOI: 10.1176/Appi.Ajp.2018.17070732 |
0.391 |
|
| 2018 |
Campbell ANC, Barbosa-Leiker C, Hatch-Maillette M, Mennenga SE, Pavlicova M, Scodes J, Saraiya T, Mitchell SG, Rotrosen J, Novo P, Nunes EV, Greenfield SF. Brief Report: Gender differences in demographic and clinical characteristics of patients with opioid use disorder entering a comparative effectiveness medication trial. The American Journal On Addictions. PMID 30106494 DOI: 10.1111/Ajad.12784 |
0.388 |
|
| 2018 |
Shulman M, Campbell A, Pavlicova M, Hu MC, Aharonovich E, Nunes EV. Cognitive functioning and treatment outcomes in a randomized controlled trial of internet-delivered drug and alcohol treatment. The American Journal On Addictions. PMID 30091814 DOI: 10.1111/Ajad.12769 |
0.379 |
|
| 2018 |
Levin FR, Choi CJ, Pavlicova M, Mariani JJ, Mahony A, Brooks DJ, Nunes EV, Grabowski J. How treatment improvement in ADHD and cocaine dependence are related to one another: A secondary analysis. Drug and Alcohol Dependence. 188: 135-140. PMID 29775957 DOI: 10.1016/J.Drugalcdep.2018.03.043 |
0.34 |
|
| 2018 |
Brezing CA, Choi CJ, Pavlicova M, Brooks D, Mahony AL, Mariani JJ, Levin FR. Abstinence and reduced frequency of use are associated with improvements in quality of life among treatment-seekers with cannabis use disorder. The American Journal On Addictions. PMID 29457671 DOI: 10.1111/Ajad.12660 |
0.34 |
|
| 2018 |
Notzon DP, Kelly MA, Choi CJ, Pavlicova M, Mahony AL, Brooks DJ, Mariani JJ, Levin FR. Open-label pilot study of injectable naltrexone for cannabis dependence. The American Journal of Drug and Alcohol Abuse. 1-9. PMID 29420073 DOI: 10.1080/00952990.2017.1423321 |
0.31 |
|
| 2017 |
Kidd JD, Tross S, Pavlicova M, Hu MC, Campbell ANC, Nunes EV. Sociodemographic and Substance Use Disorder Determinants of HIV Sexual Risk Behavior in Men and Women in Outpatient Drug Treatment in the NIDA National Drug Abuse Treatment Clinical Trials Network. Substance Use & Misuse. 52: 858-865. PMID 28426361 DOI: 10.1080/10826084.2016.1264971 |
0.356 |
|
| 2017 |
Campbell AN, Montgomery L, Sanchez K, Pavlicova M, Hu M, Newville H, Weaver L, Nunes EV. Racial/ethnic subgroup differences in outcomes and acceptability of an Internet-delivered intervention for substance use disorders. Journal of Ethnicity in Substance Abuse. 1-19. PMID 28368740 DOI: 10.1080/15332640.2017.1300550 |
0.328 |
|
| 2017 |
Sullivan M, Bisaga A, Pavlicova M, Choi CJ, Mishlen K, Carpenter KM, Levin FR, Dakwar E, Mariani JJ, Nunes EV. Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus Buprenorphine. The American Journal of Psychiatry. appiajp201616050548. PMID 28068780 DOI: 10.1176/Appi.Ajp.2016.16050548 |
0.325 |
|
| 2017 |
Olonoff M, Pavlicova M, Evans S, Mariani JJ, Choi J, Brooks DJ, Mahony A, Levin FR. Craving and anxiety responses to laboratory stress for individuals seeking treatment for cannabis use disorder: A pilot study Drug and Alcohol Dependence. 171: e155-e156. DOI: 10.1016/J.Drugalcdep.2016.08.429 |
0.319 |
|
| 2016 |
Notzon DP, Mariani JJ, Pavlicova M, Glass A, Mahony AL, Brooks DJ, Grabowski J, Levin FR. Mixed-amphetamine salts increase abstinence from marijuana in patients with co-occurring attention-deficit/hyperactivity disorder and cocaine dependence. The American Journal On Addictions. 25: 666-672. PMID 28051838 DOI: 10.1111/Ajad.12467 |
0.344 |
|
| 2016 |
Lévesque A, Campbell AN, Pavlicova M, Hu MC, Walker R, McClure EA, Ghitza UE, Bailey G, Stitzer M, Nunes EV. Coping strategies as a mediator of internet-delivered psychosocial treatment: Secondary analysis from a NIDA CTN multisite effectiveness trial. Addictive Behaviors. 65: 74-80. PMID 27776269 DOI: 10.1016/J.Addbeh.2016.09.012 |
0.377 |
|
| 2016 |
Campbell AN, Brooks AJ, Pavlicova M, Hu MC, Hatch-Maillette MA, Calsyn DA, Tross S. Barriers to Condom Use: Results for Men and Women Enrolled in HIV Risk Reduction Trials in Outpatient Drug Treatment. Journal of Hiv/Aids & Social Services. 15: 130-146. PMID 27766067 DOI: 10.1080/15381501.2016.1166090 |
0.332 |
|
| 2016 |
Tofighi B, Campbell AN, Pavlicova M, Hu MC, Lee JD, Nunes EV. Recent Internet Use and Associations with Clinical Outcomes among Patients Entering Addiction Treatment Involved in a Web-Delivered Psychosocial Intervention Study. Journal of Urban Health : Bulletin of the New York Academy of Medicine. PMID 27653383 DOI: 10.1007/S11524-016-0077-2 |
0.366 |
|
| 2016 |
Notzon DP, Pavlicova M, Glass A, Mariani JJ, Mahony AL, Brooks DJ, Levin FR. ADHD Is Highly Prevalent in Patients Seeking Treatment for Cannabis Use Disorders. Journal of Attention Disorders. PMID 27033880 DOI: 10.1177/1087054716640109 |
0.316 |
|
| 2015 |
Levin FR, Mariani JJ, Pavlicova M, Brooks D, Glass A, Mahony A, Nunes EV, Bisaga A, Dakwar E, Carpenter KM, Sullivan MA, Choi JC. Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial. Drug and Alcohol Dependence. PMID 26711160 DOI: 10.1016/J.Drugalcdep.2015.11.025 |
0.387 |
|
| 2015 |
Tross S, Feaster DJ, Thorens G, Duan R, Gomez Z, Pavlicova M, Hu MC, Kyle T, Erickson S, Spector A, Haynes L, Metsch LR. Substance Use, Depression and Sociodemographic Determinants of HIV Sexual Risk Behavior in Outpatient Substance Abuse Treatment Patients. Journal of Addiction Medicine. 9: 457-63. PMID 26501786 DOI: 10.1097/Adm.0000000000000162 |
0.362 |
|
| 2015 |
Thorens G, Pavlicova M, Hu MC, Nunes EV, Campbell AN, Tross S. Comparison of 2 Measures of HIV Sexual Risk Behavior in Women in Outpatient Drug Treatment Programs. Journal of Addiction Medicine. 9: 454-6. PMID 26501785 DOI: 10.1097/Adm.0000000000000159 |
0.324 |
|
| 2015 |
Bisaga A, Sullivan MA, Glass A, Mishlen K, Pavlicova M, Haney M, Raby WN, Levin FR, Carpenter KM, Mariani JJ, Nunes EV. The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone. Drug and Alcohol Dependence. PMID 26187456 DOI: 10.1016/J.Drugalcdep.2015.05.013 |
0.314 |
|
| 2015 |
Cooper ZD, Johnson KW, Pavlicova M, Glass A, Vosburg SK, Sullivan MA, Manubay JM, Martinez DM, Jones JD, Saccone PA, Comer SD. The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid-dependent volunteers. Addiction Biology. PMID 25975386 DOI: 10.1111/Adb.12261 |
0.325 |
|
| 2015 |
Mogali S, Khan NA, Drill ES, Pavlicova M, Sullivan MA, Nunes E, Bisaga A. Baseline characteristics of patients predicting suitability for rapid naltrexone induction. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 24: 258-64. PMID 25907815 DOI: 10.1111/Ajad.12180 |
0.338 |
|
| 2015 |
Haney M, Ramesh D, Glass A, Pavlicova M, Bedi G, Cooper ZD. Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 25881117 DOI: 10.1038/Npp.2015.108 |
0.371 |
|
| 2015 |
Campbell AN, Nunes EV, Pavlicova M, Hatch-Maillette M, Hu MC, Bailey GL, Sugarman DE, Miele GM, Rieckmann T, Shores-Wilson K, Turrigiano E, Greenfield SF. Gender-based Outcomes and Acceptability of a Computer-assisted Psychosocial Intervention for Substance Use Disorders. Journal of Substance Abuse Treatment. 53: 9-15. PMID 25613105 DOI: 10.1016/J.Jsat.2014.12.006 |
0.378 |
|
| 2015 |
McClure EA, Campbell AN, Pavlicova M, Hu M, Winhusen T, Vandrey RG, Ruglass LM, Covey LS, Stitzer ML, Kyle TL, Nunes EV. Cigarette Smoking During Substance Use Disorder Treatment: Secondary Outcomes from a National Drug Abuse Treatment Clinical Trials Network study. Journal of Substance Abuse Treatment. 53: 39-46. PMID 25595301 DOI: 10.1016/J.Jsat.2014.12.007 |
0.347 |
|
| 2015 |
Levesque A, Campbell A, Pavlicova M, Hu M, Nunes EV. Coping strategies as a mediator of internet-delivered psychosocial treatment: Secondary analysis from a NIDA CTN multisite effectiveness trial Drug and Alcohol Dependence. 156. DOI: 10.1016/J.Drugalcdep.2015.07.347 |
0.357 |
|
| 2015 |
Vaughan B, Mariani JJ, Pavlicova M, Glass A, Bisaga A, Nunes EV, Brooks DJ, Levin FR. Secondary analysis of smoking rates from a double-blind, placebo-controlled clinical trial of mixed-amphetamine salts and topiramate for cocaine dependence Drug and Alcohol Dependence. 146: e10. DOI: 10.1016/J.Drugalcdep.2014.09.709 |
0.303 |
|
| 2015 |
Kelly MA, Mariani JJ, Glass A, Pavlicova M, Radin A, Levin FR. Synthetic cannabinoid use among treatment seeking substance users Drug and Alcohol Dependence. 146: e155-e156. DOI: 10.1016/J.Drugalcdep.2014.09.340 |
0.309 |
|
| 2015 |
Evans E, Mishlen K, Glass A, Pavlicova M, Mariani JJ, Levin FR, Sullivan M. A comparison of young adults seeking treatment for cannabis and opioid dependence Drug and Alcohol Dependence. 146. DOI: 10.1016/J.Drugalcdep.2014.09.209 |
0.316 |
|
| 2014 |
Mariani JJ, Pavlicova M, Mamczur AK, Bisaga A, Nunes EV, Levin FR. Open-label pilot study of quetiapine treatment for cannabis dependence. The American Journal of Drug and Alcohol Abuse. 40: 280-4. PMID 24963729 DOI: 10.3109/00952990.2014.884102 |
0.35 |
|
| 2014 |
Raby WN, Sanfilippo L, Pavlicova M, Carpenter KM, Glass A, Onyemekwu C, Roginek E, Nunes EV. Dysregulation of diurnal cortisol secretion affects abstinence induction during a lead-in period of a clinical trial for depressed cocaine-dependent patients. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 23: 1-6. PMID 24313234 DOI: 10.1111/J.1521-0391.2013.12060.X |
0.333 |
|
| 2014 |
Thorens G, Hu M, Pavlicova M, Nunes EV, Campbell A, Tross S. A brief measure assessing sexual risk behavior in women in substance abuse treatment Drug and Alcohol Dependence. 140. DOI: 10.1016/J.Drugalcdep.2014.02.625 |
0.315 |
|
| 2013 |
Hasin DS, Aharonovich E, O'Leary A, Greenstein E, Pavlicova M, Arunajadai S, Waxman R, Wainberg M, Helzer J, Johnston B. Reducing heavy drinking in HIV primary care: a randomized trial of brief intervention, with and without technological enhancement. Addiction (Abingdon, England). 108: 1230-40. PMID 23432593 DOI: 10.1111/Add.12127 |
0.305 |
|
| 2013 |
Levin FR, Mariani J, Brooks DJ, Pavlicova M, Nunes EV, Agosti V, Bisaga A, Sullivan MA, Carpenter KM. A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders. Addiction (Abingdon, England). 108: 1084-94. PMID 23297841 DOI: 10.1111/Add.12108 |
0.326 |
|
| 2012 |
Mariani JJ, Pavlicova M, Bisaga A, Nunes EV, Brooks DJ, Levin FR. Extended-release mixed amphetamine salts and topiramate for cocaine dependence: a randomized controlled trial. Biological Psychiatry. 72: 950-6. PMID 22795453 DOI: 10.1016/J.Biopsych.2012.05.032 |
0.315 |
|
| 2012 |
Mantovani A, Pavlicova M, Avery D, Nahas Z, McDonald WM, Wajdik CD, Holtzheimer PE, George MS, Sackeim HA, Lisanby SH. Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression. Depression and Anxiety. 29: 883-90. PMID 22689290 DOI: 10.1002/Da.21967 |
0.315 |
|
| 2012 |
Campbell AN, Tross S, Hu MC, Pavlicova M, Nunes EV. Predictors of relationship power among drug-involved women. Aids and Behavior. 16: 1532-41. PMID 22614746 DOI: 10.1007/S10461-012-0208-Z |
0.317 |
|
| 2011 |
Campbell AN, Tross S, Hu MC, Pavlicova M, Kenney J, Nunes EV. Female condom skill and attitude: results from a NIDA Clinical Trials Network gender-specific HIV risk reduction study. Aids Education and Prevention : Official Publication of the International Society For Aids Education. 23: 329-40. PMID 21861607 DOI: 10.1521/Aeap.2011.23.4.329 |
0.331 |
|
| 2011 |
Nunes EV, Pavlicova M, Hu MC, Campbell AN, Miele G, Hien D, Klein DF. Baseline matters: the importance of covariation for baseline severity in the analysis of clinical trials. The American Journal of Drug and Alcohol Abuse. 37: 446-52. PMID 21854289 DOI: 10.3109/00952990.2011.596980 |
0.373 |
|
| 2011 |
Hu MC, Pavlicova M, Nunes EV. Zero-inflated and hurdle models of count data with extra zeros: examples from an HIV-risk reduction intervention trial. The American Journal of Drug and Alcohol Abuse. 37: 367-75. PMID 21854279 DOI: 10.3109/00952990.2011.597280 |
0.309 |
|
| 2011 |
Schweitzer PJ, Zafar U, Pavlicova M, Fallon BA. Long-term follow-up of hypochondriasis after selective serotonin reuptake inhibitor treatment. Journal of Clinical Psychopharmacology. 31: 365-8. PMID 21508861 DOI: 10.1097/Jcp.0B013E31821896C3 |
0.333 |
|
| 2011 |
Levin FR, Mariani JJ, Brooks DJ, Pavlicova M, Cheng W, Nunes EV. Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial. Drug and Alcohol Dependence. 116: 142-50. PMID 21310551 DOI: 10.1016/J.Drugalcdep.2010.12.010 |
0.393 |
|
| 2010 |
George MS, Lisanby SH, Avery D, McDonald WM, Durkalski V, Pavlicova M, Anderson B, Nahas Z, Bulow P, Zarkowski P, Holtzheimer PE, Schwartz T, Sackeim HA. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Archives of General Psychiatry. 67: 507-16. PMID 20439832 DOI: 10.1001/Archgenpsychiatry.2010.46 |
0.356 |
|
| 2009 |
Tross S, Hanner J, Hu MC, Pavlicova M, Campbell A, Nunes EV. Substance use and high risk sexual behaviors among women in psychosocial outpatient and methadone maintenance treatment programs. The American Journal of Drug and Alcohol Abuse. 35: 368-74. PMID 20180666 DOI: 10.1080/00952990903108256 |
0.358 |
|
| 2009 |
Zarkowski P, Navarro R, Pavlicova M, George MS, Avery D. The effect of daily prefrontal repetitive transcranial magnetic stimulation over several weeks on resting motor threshold. Brain Stimulation. 2: 163-7. PMID 20161065 DOI: 10.1016/J.Brs.2009.02.001 |
0.331 |
|
| 2009 |
Campbell AN, Tross S, Dworkin SL, Hu MC, Manuel J, Pavlicova M, Nunes EV. Relationship power and sexual risk among women in community-based substance abuse treatment. Journal of Urban Health : Bulletin of the New York Academy of Medicine. 86: 951-64. PMID 19921541 DOI: 10.1007/S11524-009-9405-0 |
0.309 |
|
| 2009 |
Cohen LR, Tross S, Pavlicova M, Hu MC, Campbell AN, Nunes EV. Substance use, childhood sexual abuse, and sexual risk behavior among women in methadone treatment. The American Journal of Drug and Alcohol Abuse. 35: 305-10. PMID 19637103 DOI: 10.1080/00952990903060127 |
0.33 |
|
| 2008 |
Tross S, Campbell AN, Cohen LR, Calsyn D, Pavlicova M, Miele GM, Hu MC, Haynes L, Nugent N, Gan W, Hatch-Maillette M, Mandler R, McLaughlin P, El-Bassel N, Crits-Christoph P, et al. Effectiveness of HIV/STD sexual risk reduction groups for women in substance abuse treatment programs: results of NIDA Clinical Trials Network Trial. Journal of Acquired Immune Deficiency Syndromes (1999). 48: 581-9. PMID 18645513 DOI: 10.1097/Qai.0B013E31817Efb6E |
0.347 |
|
| Show low-probability matches. |